Glutamate Carboxypeptidase II Gene Expression in the Human Frontal and Temporal Lobe in Schizophrenia

Neuropsychopharmacology

Volumn 29, Issue 1, 2004, Pages 117-125

  Ghose, Subroto ^a   Weickert, Cynthia Shannon ^a   Colvin, Sarah M ^a   Coyle, Joseph T ^b   Herman, Mary M ^a   Hyde, Thomas M ^a   Kleinman, Joel E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CA3; Glia; mRNA; NAAG; NAALADase; Polymorphic

Indexed keywords

GAMMA GLUTAMYL HYDROLASE; GAMMA GLUTAMYL HYDROLASE II; SILVER; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CADAVER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENTORHINAL CORTEX; ENZYME ACTIVITY; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IN SITU HYBRIDIZATION; MACACA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PH MEASUREMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL LOBE; WHITE MATTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BINDING SITES; CARBOXYPEPTIDASES; CHLORPROMAZINE; COHORT STUDIES; DIPEPTIDES; DNA, COMPLEMENTARY; FEMALE; FRONTAL LOBE; GENE EXPRESSION; HAPLORHINI; HIPPOCAMPUS; HUMANS; HYDROGEN-ION CONCENTRATION; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); NEUROGLIA; NEUROTOXINS; RNA, MESSENGER; SCHIZOPHRENIA; SILVER STAINING; TEMPORAL LOBE;

EID: 0346057787     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300304     Document Type: Article

References (47)

1. Amaral D, Insausti R (1990). Hippocampal formation. In: Paxinos G (ed). The Human Nervous System. Academic Press: San Diego, CA. pp 711-756.
2. Bachus SE, Hyde TM, Shannon Weickert C, Shashidharan P, Herman MM, Kleinman JE (1996). Reduced level of excitatory amino acid transporter 3 mRNA in hippocampus of schizophrenics. Soc Neurosci Abstract 26: 112.
3. Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, Konradi C et al (1999). Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol 415: 52-64.
4. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT et al (1996). Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 15: 1554-1563.
5. Cartmell J, Monn JA, Schoepp DD (2000). Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine. Psychopharmacology (Berl) 148: 423-429.
6. Coyle JT (1997). The nagging question of the function of N-acetylaspartylglutamate. Neurobiol Dis 4: 231-237.
7. Dean B, Scarr E, Bradbury R, Copolov D (1999). Decreased hippocampal (CA3) NMDA receptors in schizophrenia. Synapse 32: 67-69.
8. Deicken RF, Pegues M, Amend D (1999). Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia. Schizophr Res 37: 217-223.
9. Du F, Okuno E, Whetsell Jr WO, Kohler C, Schwarcz R (1990). Distribution of quionolinic acid phosphoribosyltransferase in the human hippocampal formation and parahippocampal gyrus. J Comp Neurol 295: 71-82.
10. Eastwood SL, Harrison PJ (1995a). Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69: 339-343.
11. Eastwood SL, Harrison PJ (1999). Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections. Neuroscience 93: 99-106.
12. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ (1995b). Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 29: 211-223.
13. Harris KM, Rosenberg PA (1993). Localization of synapses in rat cortical cultures. Neuroscience 53: 495-508.
14. Ishizuka N, Cowan WM, Amaral D (1995). A quantitative analysis of the dendritic organization of pyramidal cells in the rat hippocampus. J Comp Neurol 362: 17-45.
15. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
16. Kleinmn JE, Hyde TM, Herman MM (1995). Methodological issues in the neuropathology of mental illness. In: loom FE, Kupfer DJ (eds). Psycopharmacology: The Fourth Generation of Progress. Raven Press: New York, pp 859-864.
17. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
18. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9-19.
19. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001). Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25: 455-467.
20. Li XG, Somogyi P, Buzsaki G (1994). The hippocampal CA3 network: An in vivo intracellular labeling study. J Comp Neurol 339: 181-208.
21. Luthi-Carter R, Barczak AK, Speno H, Coyle JT (1998a). Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II. Brain Res 795: 341-348.
22. Luthi-Carter R, Barczak AK, Speno H, Coyle JT (1998b). Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther 286: 1020-1025.
23. McBain CJ, Fisahn A (2001). Interneurons unbound. Nat Rev Neurosci 2: 11-18.
24. Moghaddam B, Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352.
25. Neale JH, Bzdega T, Wroblewska B (2000). N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75: 443-452.
26. Passani LA, Vonsattel JP, Coyle JT (1997). Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease. Brain Res 772: 9-22.
27. Paxinos G, Huang X, Toga AW (2000). The Rhesus Monkey Brain in Stereotaxic Coordinates. New York: Academic Press. Figure 66.
28. Porter RH, Eastwood SL, Harrison PJ (1997). Distribution of Kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res 751: 217-231.
29. Rajkowska G, Goldman-Rakic PS (1995). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 5: 307-322.
30. Renno WM, Lee JH, Beitz AJ (1997). Light and electron microscopic immunohistochemical localization of N-acetylaspartylglutamate (NAAG) in the olivocerebellar pathway of the rat. Synapse 26: 140-154.
31. Rosene DL, van Hoesen GW (1987). The hippocampal formation of the primate brain. A review of some comparative aspects of cytoarchitecture and connections. In: Jones EG, Peters A (eds). Cerebral Cortex, Vol 6. Plenum Press: New York, pp 273-280.
32. Sekiguchi M, Wada K, Wenthold RJ (1992). N-acetylaspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR1) expressed in Xenopus oocytes. FEBS Lett 311: 285-289.
33. Semple CA, Devon RS, Le Hellard S, Porteous DJ (2001). Identification of genes from a schizophrenia-linked translocation breakpoint region. Genomics 73: 123-126.
34. Sik A, Tamamaki N, Freund TF (1993). Complete axon arborization of a single CA3 pyramidal cell in the rat hippocampus, and its relationship with postsynaptic parvalbumin-containing interneurons. Eur J Neuroscience 5: 1719-1728.
35. Slusher BS, Robinson MP, Tsai G, Simmins ML, Richards SS, Coyle JT (1990). Rat brain N-acetyled alpha linked acidic dipeptidase activity: purification and immunologic characterization. J Biol Chem 265: 21297-21301.
36. Slusher BS, Tsai G, Yoo G, Coyle JT (1992). Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Comp Neurol 315: 217-229.
37. Stauch-Slusher B, Robinson MB, Forloni G, Tsai G, Coyle JT (1989). The effects of N-acetylated-1α-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo. Neurosci Lett 100: 295-300.
38. Trombley PQ, Westbrook GL (1990). Excitatory synaptic transmission in cultures of rat olfactory bulb. J Neurophysiol 64: 598-606.
39. Tsai G, Coyle JT (2002). Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42: 165-179.
40. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE et al (1995). Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52: 829-836.
41. Tsai G, Stauch BL, Vornov JJ, Deshpande JK, Coyle JT (1990). Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo. Brain Res 518: 313-316.
42. Webster MJ, Shannon Weickert C, Herman MM, Hyde TM, Kleinman JE (2001). Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia. Schizophr Res 49: 89-98.
43. Westbrook GL, Mayer ML, Namboodiri MA, Neale JH (1986). High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J Neurosci 6: 3385-3392.
44. Whitfield HJ, Brady LS, Smith MA, Mamalaki E, Fox RJ, Herkenham M (1990). Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell Mol Neurobiol 10: 145-157.
45. Williamson LC, Neale JH (1988a). Ultrastructural localization of N-acetylaspartylglutamate in synaptic vesicles of retinal neurons. Brain Res 456: 375-381.
46. Williamson LC, Neale JH (1988b). Calcium-dependent release of N-acetylaspartylglutamate from retinal neurons upon depolarization. Brain Res 475: 151-155.
47. Wroblewska B, Santi MR, Neale JH (1998). N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 24: 172-179.